Steve Jobs’ son starts new firm to focus on cancer research

Reed Jobs' new investment fund will focus on cancer treatment research
Jobs' father, Steve Jobs, died from cancer in 2011
Firm is a for-profit business, will still accept donations for grant use

Updated: Aug 1, 2023 / 11:15 AM CDT

SAN FRANCISCO – JANUARY 10: Apple CEO Steve Jobs delivers the keynote address during the 2006 Macworld January 10, 2006 in San Francisco, California. Jobs announced a new iMac with Intel Core Duo processor as well as the new MacBook Pro laptop. (Photo by Justin Sullivan/Getty Images)

Mortgage Calculator

This calculator helps you estimate your monthly mortgage payment. It adds up the loan payment (principal + interest), property tax, and insurance. The loan payment is spread out over the years of your loan term.

Loan Amount ($):

This is the total amount you're borrowing from the bank.

Annual Interest Rate (%):

This is the yearly interest rate on your loan.

Loan Term (years):

This is how long you'll take to repay the loan.

Annual Property Tax ($):

This is the yearly tax you pay on your property.

Annual Homeowners Insurance ($):

This is the yearly cost to insure your home.

Monthly Payment Breakdown

Principal and Interest: $

Property Tax: $

Homeowners Insurance: $

Total Estimated Monthly Payment: $

CHICAGO (NewsNation) — Steve Jobs’s son, Reed Jobs, is starting a new venture capital investment firm focused on cancer treatment research, according to a New York Times report.

Reed’s father, the co-founder of Apple, died from pancreatic cancer complications in 2011. Since then, Reed has been focusing on oncology in hopes of improving cancer treatments, the report said.

“My dad succumbed to cancer when I was in college at Stanford,” Reed said. “I was pre-med because I really wanted to be a doctor and cure people myself. But just completely candidly, it was really difficult after he passed away.”

The 31-year-old created Yosemite, a spinoff from his mother’s firm Emerson Collective, USA Today reported. Since starting, his firm has raised $200 million from investors and institutions, the NYT reported.

Reed’s firm will run as a for-profit business, but will still receive donations for grants given to scientists with no strings attached, the NYT reported.